Evidence map›Paper›PMID 41023948›Full record

ArticleBMC infectious diseases2025

Nanoparticle-based biosensors coupled with loop-mediated isothermal amplification for rapid, visual, and in-field identification of pathogenic Leptospira.

Ling Xie, Ying Liu, Xinggui Yang, Shijun Li, Xu Chen

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ling XieThe Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China.
Ying LiuExperimental Center, Guizhou Provincial Centre for Disease Control and Prevention, Guiyang, Guizhou, 550004, People's Republic of China.
Xinggui YangExperimental Center, Guizhou Provincial Centre for Disease Control and Prevention, Guiyang, Guizhou, 550004, People's Republic of China.
Shijun LiExperimental Center, Guizhou Provincial Centre for Disease Control and Prevention, Guiyang, Guizhou, 550004, People's Republic of China. zjumedjun@163.com.
Xu ChenThe Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China. xuchen1220@126.com.

Funding

National Natural Science Foundation of China 82202556the Key Laboratory of Microbiol and Infectious Disease Prevention & Control in Guizhou Province Grant no. Qiankehe Platform Talent ZDSYS [2023]004the Project for Public Health Talent Cultivation of China Grant no. Guo Jikong Zong Ren Han [2024]122
6 · The paper itself

Abstract

backgroundLeptospirosis is a worldwide re-emerging zoonotic infectious disease caused by pathogenic spirochetes of the Leptospira genus. The clinical symptoms at leptospirosis onset are similar to those of other febrile illnesses, and early etiological identification of pathogenic Leptospira spp. is crucial to initiate immediate treatment and limit transmission. Here, we report a new molecular diagnostic assay termed loop-mediated isothermal amplification combined with a visual gold nanoparticle-based lateral flow biosensor (LAMP-AuNP-LFB) for rapid, specific, sensitive, and visual identification of pathogenic Leptospira strains.

methodsThe AuNP-based LFB used here was successfully manufactured according to our device manual. The successful design of our unique Leptospira-LAMP primers was based on the lipL41 gene from reference strains of 15 serovars representing 15 serogroups of pathogenic Leptospira spp. in China. The reaction conditions, including amplification temperature and time, were optimized, and the sensitivity and specificity of our assay were verified. The feasibility of our assay was tested through field mouse and leptospirosis clinical samples.

resultsThe AuNPs-based LFB used our study was successfully manufactured. The unique pathogenic Leptospira degenerate primers were successfully designed based on the lipL41 gene. The optimal Leptospira-LAMP-AuNP-LFB detection process, including rapid nucleic acid isolation (less than 5 min), LAMP reaction (67 °C for 35 min), and visual AuNP-LFB readout (less than 2 min), could be accomplished within 45 min. Our assay detected target genes with as few as 5 copies per test and showed no cross-reactivity with other microbes in our study. The Leptospira-LAMP-AuNP-LFB assay results were consistent with culture-sequencing results in field mouse and leptospirosis clinical samples.

conclusionsThe Leptospira-LAMP-AuNP-LFB assay is a valuable tool and has tremendous potential as a point-of-care (POC) testing approach for screening for pathogenic Leptospira infection, especially in resource-poor settings.

Indexed as

Biosensing TechniquesLeptospiraLeptospirosisMetal NanoparticlesMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesAnimalsDNA, BacterialDNA PrimersGoldHumansMiceRapid Diagnostic TestsSensitivity and SpecificityDNA, BacterialDNA PrimersGoldGold nanoparticle-based lateral flow assayLeptospiraLimit of detectionLoop-mediated isothermal amplificationPoint-of-care platform

Identifiers

PMID41023948
PMCPMC12482030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.